ABSA International
ABSA International

Resources with keywords: covid-19



COVID-19 Community Levels (NEW 2/3, Website, Regulatory)
CDC

CDC is launching a new tool to monitor COVID-19 Community Levels. Each county’s COVID-19 Community Level is ranked as low, medium, or high. The community level, updated regularly, will be tied to high, medium or low precautions based on certain factors such as hospitalizations, cases and beds filled.

New Studies Contend: Wuhan Market Animals, Not Laboratory, First Infected Humans with SARS-COV2 (Website, News)
Health Policy Watch
28 February 2022
keywords: covid-19, origin
Changes in skin wrinkles and pores due to long-term mask wear (Website)
Skin Research Technology
27 February 2022

Park, M et.al.
This study investigated changes in skin wrinkles and pores caused by long-term mask wear and whether or not use of moisturizers has an effect on any changes.

keywords: covid-19, facemask
Heat inactivation of clinical COVID-19 samples on an industrial scale for low risk and efficient high-throughput qRT-PCR diagnostic testing (Website, Publication)
Scientific Reports
21 February 2022

Delpuech O, Douthwaite JA, Hill T, et al.
Heating as the sole method of virus inactivation is ideally suited to streamlined and more rapid workflows such as ‘direct to PCR’ assays that do not involve RNA extraction or chemical neutralisation methods.

Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022 (Website, Publication)
CDC/MMWR
18 February 2022

Ferdinands JM, Rao S, Dixon BE, et al.

keywords: covid-19, Delta, mRNA, omicron
Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5–17 Years — VISION Network, 10 States, April 2021–January 2022 (Website, Publication)
CDC/MMWR
18 December 2021

Klein NP, Stockwell MS, Demarco M, et al.
Two doses protect against COVID-19–associated emergency department and urgent care encounters among children and adolescents. However, vaccine effectiveness (VE) was lower during Omicron predominance and decreased with time since vaccination; a booster dose restored VE to 81% among adolescents aged 16–17 years. Overall, 2-dose VE against COVID-19–associated hospitalization was 73%–94%.

SARS-CoV-2 in the Air: What’s Known and What Isn’t (NEW 3/7, Website, Publication, News)
The Scientist
18 February 2022

Evidence suggests that COVID-19 is primarily an airborne disease. Yet the details of how transmission occurs are still debated and frequently misunderstood.

Quantitative SARS-CoV-2 Viral-Load Curves in Paired Saliva Samples and Nasal Swabs Inform Appropriate Respiratory Sampling Site and Analytical Test Sensitivity Required for Earliest Viral Detection (Website, Publication)
Journal of Clinical Microbiology
16 February 2021

Savela ES, et al.

The authors state: “Our study illustrates the value of acquiring early (within hours after a negative high-sensitivity test) viral-load profiles to guide the appropriate analytical sensitivity and respiratory site for detecting earliest infections.”

keywords: covid-19, saliva, testing
Effectiveness of Maternal Vaccination with mRNA COVID-19 Vaccine During Pregnancy Against COVID-19–Associated Hospitalization in Infants Aged <6 Months — 17 States, July 2021–January 2022 (Website, Publication)
CDC/MMWR
15 February 2022

Halasa NB, Olson SM, Staat MA, et al.
Completion of a 2-dose mRNA COVID-19 vaccination series during pregnancy might help prevent COVID-19 hospitalization among infants aged <6 months.

Coronavirus (COVID-19) Update: FDA Authorizes New Monoclonal Antibody for Treatment of COVID-19 that Retains Activity Against Omicron Variant (Website, Regulatory)
FDA
11 February 2022
Go to Top